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A B S T R A C T
This study was designed to evaluate the costs between 2005 and 2013 of the national bluetongue virus
(BTV) surveillance and vaccination programmes before, during and after the BTV serotype 8 (BTV-8) out-
break in Austria commencing in 2008. In addition to an assessment of the temporal development of costs,
a spatial cost analysis was performed. Within the context of this study, the term ‘costs’ refers to actual
ﬁnancial expenditure and imputed monetary costs for contributions in-kind. Costs were ﬁnanced di-
rectly by the private–public sectors, by the European Commission (EC), and (in-kind) by responsible national
institutions and individuals (e.g. blood sampling by veterinarians).
The total net cost of the BTV-8 surveillance and vaccination programmes arising from the outbreak
amounted to €22.8 million (0.86% of the national agricultural Gross Value Added), of which 32% was al-
located to surveillance and 68% to the vaccination programme. Of the total programme costs, the EC supplied
€4.9 million, while the remaining costs (€18 million) were directly ﬁnanced from national resources. Of
the latter, €14.5 million was classed as public costs, including €2 million contributions in-kind, and €3.4
million as private costs. The assessment of the costs revealed heterogeneous temporal and spatial dis-
tributions. The methodology of this analysis might assist decision makers in calculating costs for other
surveillance and intervention programmes. The assessment of contributions in-kind is of importance to
public authorities as it increases visibility of the available resources and shows how they have been em-
ployed. This study also demonstrates the importance of tracking changing costs per payer over time.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Economic assessment of animal health surveillance programmes
is an important aspect of veterinary medicine and is attracting in-
creasing attention. Bluetongue virus serotype 8 (BTV-8) was reported
in Europe for the ﬁrst time in 2006 (Müller et al., 2010; Saegerman
et al., 2011; Coetzee et al., 2013). Initial cases emerged in the border
regions between The Netherlands, Belgium, Germany and Luxem-
bourg (Gloster et al., 2007; Elbers et al., 2008; Saegerman et al., 2008;
Kirschvink et al., 2009), and the ﬁrst Austrian case of BTV-8 was
detected in November 2008 (Loitsch et al., 2009).
In 2008, the European Union (EU) mobilised approximately €165
million1 for BTV control programmes inMember States, with a further
€66million in 2009.While substantial EU contributions for large-scale
vaccinationprogrammes (e.g. rabies) havepreviously beendocumented,2
analyses focusing on resource allocation of surveillance programmes
are limited (Rich et al., 2013). One reason for this is the diﬃculty in ob-
taining accurate information on costs and tangible beneﬁts of
surveillance programmes (Drewe et al., 2013a). Moreover, it is essen-
tial to consider changes in costs over time, as surveillance programmes
will differ in duration, according to the objectives and goals of decision
makers (Rich et al., 2013). Recently, Häsler et al. (2012) retrospec-
tively estimated the costs and beneﬁts of the BTV surveillance and
interventionprogrammes in Switzerlandbetween2008and2009,which
indicated that the mean cost of these programmes amounted to ap-
proximately €102,000–106,000 and €18–19 million, respectively.
In the present study, we conducted a cost analysis of the Aus-
trian BTV-8 surveillance and vaccination programmes between2005
* Corresponding author. Tel.: +43 125 077 3505.
E-mail address: beate.pinior@vetmeduni.ac.at (B. Pinior).
1 €1 = approx. US$1.08, £0.73 as at 1 April 2015.
2 See: http://ec.europa.eu/food/animal/diseases/docs/report_2007-2011_2013
-10941_en.pdf (accessed 24 July 2015).
http://dx.doi.org/10.1016/j.tvjl.2015.07.032
1090-0233/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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and 2013.Within the context of this study, the term ‘costs’ refers to
actual ﬁnancial expenditure and imputed monetary costs for con-
tributions in-kind. The objectives were to estimate the cost of the
programmesbefore, during, andafter thediseaseoutbreakand,where
the highest costs were incurred, to deﬁne the proportion of costs
ﬁnanced by the public and private sectors and the European Com-
mission (EC), and to analyse the proportion of costs directly ﬁnanced
and the proportion provided as contributions in-kind by various na-
tional authorities and individuals. Linear regression models were
applied to analysewhether costs couldbepredictedusing information
readily available in the public domain (e.g. animal populations).
Materials and methods
Description of the surveillance and intervention programmes
Prior to the European BTV-8 outbreak in 2006, only marginal BTV surveillance
activities were conducted in Austria. From 2007 onward, both active and passive BTV
surveillance programmes were implemented in accordance with EU regulation
1266/20073 (Fig. 1). Routine BTV sampling was also undertaken based on imports,
exports and national trade of livestock.
Samples were collected in designated BTV areas, according to a risk-based sam-
pling plan. Geographical areas were classiﬁed according to the expected BTV risk,
using criteria such as livestock density, vector activity and climate. The country was
divided into 28 geographical units, fromwhich 91 animals per unit were tested each
month between 2007 and 2010. From 2011, the country was divided into four units,
from which a total of 301 animals were tested from mid-September to December
(see Appendix: Supplementary Table S1).
As part of sentinel surveillance, 150 cattle per geographical unit per month were
tested (maximum of 10 cattle per farm). In 2008, bulk milk samples from routine
milk testing were tested by ELISA for the presence of antibodies to BTV,4 although
milk testing was discontinued once animals had been vaccinated. Serological as-
sessment of blood samples was undertaken at the oﬃcial laboratories of the Austrian
Agency for Health and Food Safety (Österreichische Agentur für Ernährungssicherheit,
AGES) and by various regional veterinary authorities.
Due to the apparent risk of BTV transmission fromneighbouring countries and iden-
tiﬁcation of theﬁrst BTV-positive case inAustria, amandatorynationwideBTVvaccination
campaign was introduced in 2008 for all ruminants, using a commercially available in-
activated BTV-8 vaccine (Steinrigl et al., 2010).5 All goats and sheep ≥4 weeks and all
cattle ≥3 months of age were vaccinated. Sentinel animals and breeding bulls were ex-
cluded from the compulsory vaccination programme. In cattle, vaccination was carried
out twice with an interval of 4 weeks, whereas sheep and goats were vaccinated once.
The vaccination rate during themandatory periodwas around 80% (Loitsch et al., 2009).
In mid-2009, the mandatory vaccination programme was replaced by a volun-
tary scheme. To demonstrate the success of vaccination with respect to disease
mitigation and to maintain BTV disease-free status (granted in March 2011), sur-
veillance remains in place at the current time. The surveillance and vaccination
programmes are summarised in Appendix: Supplementary Table S1.
Cost calculation
For the retrospective cost analysis, the years 2005–2013 were divided into three
periods as described in Fig. 1. The major cost factors were determined by analysing
the activities needed to establish and maintain surveillance and vaccination pro-
grammes, as detailed elsewhere (Pinior et al., 2015). We investigated whether these
major cost factors had been documented or could be based on legal decrees, e.g.
3 See: http://eur-lex.europa.eu/legal-content/EN/TXT/HTML/?uri=CELEX
:32007R1266&from=EN (accessed 25 July 2015).
4 See: http://www.ages.at/ﬁleadmin/AGES2015/Service/Tiergesundheit/
JahresBerichte/BTV-Abschlussbericht_2008.pdf (accessed 24 July 2015).
5 See: http://www.efsa.europa.eu/it/scdocs/doc/479.pdf (accessed 24 July 2015).
Fig. 1. Timeline of Austrian BTV surveillance and intervention activities: Period 1 (pre-outbreak) represents the costs that arose from the beginning of the surveillance period
to the ﬁrst detected BTV-positive animal; period 2 (outbreak) covers the years from the ﬁrst to the last oﬃcially conﬁrmed BTV case, up to the achievement of BTV-free
status. Period 3 (post-outbreak) starts at the date of BTV-free status (March 2011) and continued until the year 2013.
Table 1
Net costs of the surveillance and vaccination programmes for the period 2005–2013.
Major costs (€)
Surveillance programme Absolute values Relative values
Implementation costs (47.53%)
Call out charges 1,970,700
Samples taken 1,163,010
Dispatch of samples 315,312
Diagnostic costs (52.34%)
Risk based sampling 1,276,851
Sentinel 292,478
Routine 2,222,753
Passive 6325
Other costs (0.13%)
Oﬃce supplies 5997
Travel 2241
Purchase of sentinel animals 900
Total costs 7,256,567 (31.82%)
Financed by the European Commission 566,460 (7.81%)
Financed by national resources 6,690,107 (92.19%)
Vaccination programme
Implementation costs (81.51%)
Injection (€2) 7,199,088
Call-out charge (€30) 3,175,050
Call-out charge for beef suckler herd
(€40)
2,200,200
Call-out charge for alpine pasture
herdsa (€60–120/h)
100,860
Other costs (18.49%)
Vaccination doses orderedb 2,850,000
Ear tag 18,280
Information material 1667
Dispatching vaccine 1367
Court feesc 2600
Travel 1621
Total costs 15,550,733 (68.18%)
Financed by the European Commission 4,322,322 (27.80%)
Financed by national resources 11,228,411 (72.20%)
a Veterinarians received a call-out charge of €60/h for alpine pasture holdings up
to 1300 m above sea level, €90/h at 1300–1700 m, and €120/h above 1700 m.
b Note that the number of vaccine doses ordered does not necessarily corre-
spond to the number of doses used.
c A number of farmers initiated legal proceedings against the Austrian authori-
ties alleging vaccine adverse reactions having a detrimental effect on their livestock.
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veterinarians’ fees for speciﬁc activities. To collect data on major costs, access to the
accounts of the federal veterinary authorities was granted.
The net costs of the surveillance and vaccination programmes were divided into
those directly ﬁnanced and those provided as contributions in-kind from national
public institutions, such as the Federal Ministry of Health (Bundesministerium für
Gesundheit, BMG), AGES and the veterinary authorities. The latter was considered
hidden costs, based on oﬃcial agreements with the responsible parties. Data were
collected between May 2013 and August 2014 (Appendix: Supplementary Table S2).
Surveillance activities included costs for the call-out charges of veterinarians,
taking milk/blood samples, and dispatching samples from the farm to the labora-
tory for BTV diagnostic testing. All of these costs were contributed as payments in-
kind by the veterinary authorities and are detailed in Table 1. If the data for a given
year were incomplete, but the number of samples was known, then the missing data
were estimated based on full datasets from other years. In addition, we considered
the costs of consecutive laboratory tests for BTV detection.
Within the vaccination programme, costs arose for veterinary call-out fees and
the administration of vaccines. The call-out fee paid to a veterinarian was depen-
dent onwhether a beef suckler herd, an alpine pasture holdingwith different altitudes,
or another farm type was visited (see Appendix: Supplementary Fig. S1, showing
the distribution of alpine pastures by altitude).
The costs for the surveillance and vaccination programmes were analysed by year
to demonstrate how resource allocation differed over time. These costs were further
analysed according to national (private and public) and EC costs, and the level of reim-
bursement provided by the EC per year. The decision to vaccinate all ruminants in Austria
was taken within days of the ﬁrst BTV case being reported. The whole of Austria was
thendeclared a single restriction (vaccination) zonewith respect to BTV andonlyminimal
additional costs were incurred with respect to movement restrictions at that time. For
this reason, it was not necessary to take the costs of restriction zones into account, in
contrast to assessments undertaken in other countries (Tago et al., 2014).
In addition to the temporal analysis of the costs, all invoices received during both
programmes were considered according to their geographical location. For ease of
comparison, all calculated spatial costs for each political district were normalised
with regard to the total number of animals divided by the number of holdings per
political district (referred to as ‘average herd size’), based on animal population data
from the year 2009. The actual distribution of the ruminant population per species
and the associated number of holdings in each district are shown in Appendix:
Supplementary Fig. S2. These data were extracted from the oﬃcial Austrian data-
base (VIS, Veterinary Information System).
A further method of normalisation that we used was to express the pro-
gramme costs in livestock units (Drewe et al., 2013b). In Austria, one livestock unit
(LU) is equivalent to a 500 kg adult cow, or approximately 6.7 adult sheep or goats.6
Livestock units were calculated based on the Austrian ruminant population in 2009.
A linear regression model was used for both programmes to quantify the ex-
pected effect of the ruminant (cattle, sheep and goats) population (PC, PS, PG) and
the average ruminant herd size (HC, HS, HG) on the total costs per political dis-
trict. As such, the costs of vaccination were calculated as follows:
Vaccination costs PC PS PG HC HS HG= + + + + + +β β β β β β β0 1 2 3 4 5 6
For the model describing the surveillance costs, model diagnostics revealed not
normally distributed model residuals. Thus, the surveillance costs were log-
transformed as follows:
log surveillance costs PC PS PG HC HS HG( ) = + + + + + +β β β β β β β0 1 2 3 4 5 6
We aimed to reduce the models to include only the most relevant factors and
used the Akaike information criterion (AIC) to determine the best model. The AIC
uses the parsimony principle to reduce the number of factors analysed and incor-
porates both the complexity of the estimated model and how well the model ﬁts
the data (Akaike, 1973). We calculated the root-mean-square error (RMSE) to eval-
uate the predictive goodness-of-ﬁt of the ﬁnalmodels. Themodels andmaps of Austria
were implemented using the R statistical computing environment.7
Results
Total costs of the surveillance and intervention programme
Taken together, the BTV-8 programmes in Austria cost €22.81
million, of which 31.8% (€7.25 million) was allocated to surveil-
lance and 68.2% (€15.55 million) to the vaccination campaign. These
costs represent 0.86% of the Austrian Gross Value Added (GVA) for
agriculture. The total spending on livestock surveillance and vac-
cination combined was €14.14 per livestock unit, whereby €4.50 per
livestock unit was spent on BTV surveillance and €9.64 on vacci-
nation. If only the ﬁnanced costs across both programmeswere taken
into account (i.e. in-kind contributions were excluded) then €12.82
per livestock unit was funded directly. A detailed allocation of the
surveillance and vaccination costs can be found in Table 1.
Temporal and spatial analyses of the surveillance and vaccination
costs
Table 2 shows that the largest proportion of the surveillance costs
were incurred during the BTV outbreak with a share of 48.9% (€3.54
million), followed by the post-outbreak period with 39.6% (€2.87
million) and prior to the outbreak with 11.5% (€832,277). The level
of reimbursement of surveillance costs over time is shown in Fig. 2.
6 See: http://noe-bbk.lko.at/?+Merkblatt+Mehrfachantrag+Flaechen+2014+&id
=2500%2C2159860%2C%2C%2Cc2V0PTI%3D (accessed 25 July 2015). 7 See: http://www.r-project.org (accessed 2 April 2015).
Table 2
Costs in the surveillance programme over the three time periods.
Surveillance Price €/unit Period 1
Pre-outbreak
Period 2
Outbreak
Period 3
Post-outbreak
Total number Total costs
Diagnostic methods
ELISA (milk) 5.6 0 41,151 4999 46,150 258,440
ELISA (blood) 6.8 39,349a 72,664 90,509a 202,522 1,377,150
PCR 15.0 658 72,577 69,982 143,217 2,148,255
Serum neutralisation 52.6 0 141 0 141 7417
Serotyping 45.0 0 49 0 49 2205
Genome neutralisation 95.0 0 52 0 52 4940
Total number 40,007 186,634 165,490 392,131 –
Total costs 277,443 1,827,778 1,693,186 – 3,798,407
Implementation
Call out charge (COC)b 50.0 6948 21,469 10,997 39,414 1,970,700
Samples taken 5.0 30,370 93,805 108,427 232,602 1,163,010
Dispatch of samplesc 8.0 6948 21,469 10,997 39,414 315,312
Total number 44,266 136,743 130,421 311,430 –
Total costs 554,834 1,714,227 1,179,961 – 3,449,022
a For ELISAs carried out in Periods 1 and 3, the sample type (milk or blood) was not always recorded. For the cost calculation, the ELISA price for blood was therefore
used. If initial ELISA testing proved BTV-positive, results were conﬁrmed by PCR.
b Veterinarians were budgeted to receive €50 (net) per holding visited based on oﬃcial agreements with the responsible parties (e.g. a legal decree relating to oﬃcial
veterinary fees); this fee included the costs for the collection of ﬁve samples. Each additional sample cost €5. If COC data for a given year were incomplete, but the number
of samples was known, then the missing data were estimated based on full datasets from other years.
c The dispatch of samples per farm cost €8 (assumption).
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The greatest normalised total diagnostic costs were reported in
the political districts of Innsbruck Land (13.4%), Melk (7.2%) and Ried
im Innkreis (5.8%) (Fig. 3a). These districts also incurred the highest
surveillance implementation costs, which, for all three districts to-
gether, accounted for 21.8% of the total implementation costs and
31.4% of the total diagnostic costs.
Approximately 1594 million cattle, 344,000 sheep and 65,000
goats were vaccinated during the mandatory vaccination pro-
gramme. In 2009, the cost of vaccines, injection administration and
call-out charges totalled around €11.77 million (75.7%). If call-out
charges are excluded, 88.6% of the total vaccination costs were al-
located to cattle, followed by sheep (9.6%) and goats (1.8%). The
Fig. 2. Timeline of the surveillance costs and fraction of the reimbursement of costs per payer (%).
Fig. 3. (a) Total normalised surveillance costs in each political district (€000s). (b) Total normalised vaccination costs in each political district (€000s). Costs were normalised
by number of animals and number of holdings per political district. No data on the serological costs per political district were available for the years 2005–2010; these data
were therefore extrapolated from data collected between 2011 and 2013. This ﬁgure illustrates data and analysis for 96/99 political districts in Austria; the remaining three
districts (Vienna, Eisenstadt and Rust) were excluded due to their extremely low ruminant stocking densities (0–2.05 head/km2) and are labelled white.
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highest normalised vaccination costs can be found in the districts
of Spittal an der Drau and Freistadt, which together make up 5.8%
of the total vaccination costs (Fig. 3b).
Regression models
Vaccination costs increased signiﬁcantly with increasing cattle
and sheep population, and decreased with an increasingmean cattle
herd size within a district (Table 3). The coeﬃcient of determina-
tion expressed a high level of goodness-of-ﬁt (R2 = 0.97) and themean
error made by the model was RMSE = €20,521.77 per political dis-
trict. The model was found to be less suitable to describe the
surveillance costs, as the goodness-of-ﬁt of this model was lower
than that determined for vaccination costs, namely, R2 = 0.45, with
an RMSE = €137,131.90 per political district.
Discussion
The results of this study show that considerable costs were in-
curred by both the BTV-8 surveillance (€7.25million) and vaccination
programmes (€15.55 million) in Austria between 2005 and 2013.
Assessment of the costs revealed heterogeneous temporal and spatial
distributions. Overall, our analyses indicate that public costs have
decreased by a factor of 9.6 since Austria achieved ‘freedom from
disease’ status with respect to BTV, compared with the outbreak
period, and that private costs have increased by a factor of 3.1. As-
suming no further outbreaks are reported in Europe, it seems
reasonable to presume that public costs and EC co-ﬁnancing of BTV
surveillance will continue to decline in the future. The main reason
for high private costs after the outbreak was the large number of
animals exported to other countries,8 as BTV screening of animals
was necessary to promote such exports.
An estimate of the cost of the BTV surveillance and vaccination
programmes exists for Switzerland (Häsler et al., 2012) where it was
found that the costs for serological surveillancewere around six times
lower than those incurred in Austria (excluding implementation
costs), although both countries have similar numbers of animals and
BTV prevalence. In contrast, vaccination costs in Switzerland were
around 1.2× higher than those reported here. Total BTV surveil-
lance costs in Austria were calculated at €4.50 per livestock unit,
with €9.64/LU spent on the vaccination programme. This com-
pares favourably with the results reported in the UK by Drewe et al.
(2013b), where the average cost of surveillance across all live-
stock species was £4.00 per LU (approximately €5.48). However, it
should be noted that the costs reported for all ruminant species in
Austria were speciﬁc to BTV surveillance only and superﬁcial com-
parisons of such studies are diﬃcult, due to differing study
assumptions and methodology, political aims, and veterinary au-
thority infrastructure.
Data were available for 96/99 political districts in Austria and
the spatial analysis revealed a heterogeneous distribution of costs.
The greatest diagnostic costs were found in the district of Inns-
bruck Land. This can be explained by the presence of a large livestock
market and a number of private livestock traders in this district,
leading to a requirement for BTV testing prior to animal export
(to neighbouring Italy, in particular), comprising 12% of the total
diagnostic costs in Innsbruck Land. The high serological costs in some
political districts in Upper Austria can also be explained by the high
level of exports. For example, approximately 80% of the breeding
cattle exported from Upper Austria in 2011 were transported to
Turkey.9
The greatest vaccination costs occurred in the districts of Spittal
an der Drau and Freistadt. Since most of the Austrian alpine pasture
(12.5%) is located in Spittal an der Drau, veterinarians in this dis-
trict received relatively high call-out fees per hour, as charges increase
with altitude (Table 1). The cost differences between the federal state
of Lower Austria and the states of Styria, Carinthia, Salzburg and
Vorarlberg can also be explained by the additional alpine call-out
fees. Around 75% of all Austrian alpine pastures (>1300m above sea
level) are found in these latter federal states, whereas only around
0.9% of pastures in Lower Austria reach alpine altitudes.10 The dis-
tricts of Spittal an der Drau and Freistadt also contain the greatest
proportion of beef suckler herds in Austria, leading to elevated op-
erational costs.
The spatial differences in vaccination costs may have been caused
by the differing number of injections administered per species and
varying fees per farm type and location. The ﬁrst BTV outbreak in
Austria occurred in the district of Schaerding in the province of Upper
Austria (representing 24/28 of all Austrian cases), which had the
greatest stocking density of cattle nationally (92 head/km2). This is
comparable with the stocking densities of other European coun-
tries experiencing BTV outbreaks such as Belgium (84.9 head/km2)
and The Netherlands (113 head/km2) (Caporale and Giovannini,
2010).
Our results from this study have demonstrated that differences
existed between the incurred costs in Austria, the costs submitted
to the EC and the costs reimbursed by the EC. Costs associated with
diagnostic testing, undertaken as part of the routine surveillance
programme, were not (or were only partially) submitted to the EC
for reimbursement. Furthermore, the EC only funded certain costs
up to a maximum value. The difference between the active and
passive surveillance programmes (approximately €7.23 million) can
be explained by the fact that only a small number of suspected BTV
cases were reported by farmers. It has previously been suggested
that active farmer participation in surveillance programmes can be
a cost-effective method of reporting disease incidence (Souza
Monteiro et al., 2012), but it appears that Austrian farmers may not
have been actively involved in the BTV programmes.
The veterinary authorities in Austria experienced diﬃculties in
explaining the need for compulsory BTV-8 vaccination to the farming
community and there were a number of legal cases alleging adverse
reactions following vaccination and negative articles in the farming
press at the time of the outbreak. Thus, the farming community as
a whole may not have engaged fully with the surveillance and in-
tervention initiative as might have been expected when faced with
8 See: http://www.statistik.at/web_de/statistiken/aussenhandel/ (accessed 30March
2015).
9 See: http://wirtschaftsblatt.at/home/nachrichten/oesterreich/1204238/index (ac-
cessed 25 July 2015).
10 See: http://www.gruenerbericht.at/cm3/download/ﬁnish/142-almstatistik/415
-almstatistik-2009/0.html (accessed 25 July 2015).
Table 3
Tabular summary of the ﬁnal linear regression model for the surveillance and vac-
cination costs.
Estimate (β) Standard error (SE) t value P value
Vaccination
Intercept 4.42E+04 7.62E+03 5.803 <0.0001
Cattle population 5.77E+00 1.36E-01 42.388 <0.0001
Sheep population 5.95E+00 6.11E-01 9.731 <0.0001
Cattle herd size −1.26E+03 2.30E+02 −5.458 <0.0001
Goat herd size −3.41E+02 2.04E+02 −1.668 0.0987
Surveillance
Intercept 8.68E+00 2.03E-01 42.836 <0.0001
Goat population 3.03E-04 1.63E-04 1.816 0.0662
Cattle population 4.93E-05 8.10E-06 6.096 <0.0001
NB: for the model describing the surveillance costs, model diagnostics revealed not
normally distributed model residuals. Therefore, the surveillance costs were
log-transformed.
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an outbreak of infectious disease that can cause severe economic
and production losses.
The quantiﬁcation of costs in an analysis of this kind is primar-
ily dependent on the information available. As expected, there was
a lack of documentation pertaining speciﬁcally to contributions-
in-kind. The greatest level of payments-in-kind was recorded during
implementation of the surveillance programme, in contrast to the
vaccination programme where the activities were directly ﬁ-
nanced. Nonetheless, our study has shown that a signiﬁcant
proportion of the visible costs were avoided by relying on nation-
al resources (unreported costs).
Overestimation and underestimation are common issues asso-
ciated with this type of retrospective cost analysis. Combining the
implementation activities of both programmes may have led to an
overestimation of the costs, e.g., if veterinarians combined their sur-
veillance visits with vaccination of animals, or carried out tasks for
different surveillance programmes at the same time. This was the
case in 2013 when BTV and Schmallenberg virus surveillance
schemes were in operation simultaneously. In addition, a number
of activities considered to be contributions-in-kind, such as plan-
ning, were not taken into account, due to lack of data. As reported
elsewhere, planning and documentation activities made up 13% of
the total BTV vector monitoring costs (Pinior et al., 2015). In con-
trast with other countries (e.g. Switzerland), costs associated with
creating a vaccination databank were negligible, because existing
databases were already available in Austria. In Switzerland, these
costs were estimated at approximately €460,000 (Häsler et al.,
2012).
A further study limitation is that the analysis did not include the
private and public costs of voluntary vaccination in the post-
outbreak period from 2011 onwards. Consequently, although uptake
of voluntary BTV vaccination appears to be low (A. Loitsch, unpub-
lished data), the proportion of costs incurred by the private and
public sector post-outbreaks may be underestimated. A degree of
bias might have arisen through the extrapolation of spatial costs
from 2011–2013 to 2005–2010. Due to the BTV disease situation
in Germany, it is likely that more diagnostic tests were carried out
in the border region between Austria and Germany in 2007–2009
than were extrapolated.
Another limitation of the study is that the beneﬁts of the sur-
veillance and vaccination programmes have not been quantiﬁed in
economic terms. The beneﬁts of surveillance programmes, in par-
ticular, are known to be diﬃcult to quantify (Drewe et al., 2013b;
Pinior et al., 2015). While the low number of BTV-8 cases re-
ported in Austria at the height of the European outbreak appears
to support the success of the vaccination programme, a formal in-
vestigation has not been carried out. Given the relatively large
number of BTV cases seen in neighbouring countries (e.g. 11,485
cases in Germany in 2007) and subsequent economic losses asso-
ciated with these, the Austrian government made the decision to
implement a mandatory vaccination programme (Caporale and
Giovannini, 2010). Opinions are divided as to the best form of in-
tervention, with some studies suggesting targeted vaccination in high
risk areas, whereas others prefer to vaccinate all susceptible animals
nationwide (Caporale and Giovannini, 2010; Velthuis et al., 2011).
However, quantiﬁcation of vaccination outcome, such as an assess-
ment of income generated through continued animal export, was
beyond the scope of the current study.
We believe that the study ﬁndings will be useful for decision
makers, who seek to calculate costs of surveillance and vaccina-
tion programmes. While it is clear that vaccination costs rise with
an increasing number of animals, serological costs are less predict-
able, because factors such as type and number of diagnostic tests
(e.g. ELISA or PCR) per animal can substantially inﬂuence these costs.
For this reason, the mean error made by the linear model for sur-
veillance (RMSE: €137,131.90 per district) demonstrated a larger error
in cost estimation than the RMSE for vaccination (€20,521.77). A
further beneﬁt of our study is that the assessment of contribu-
tions in-kind makes these resources visible and shows how hidden
investments have been used.
Conclusions
The assessment of costs with respect to the BTV surveillance and
vaccination programmes in Austria revealed heterogeneous tem-
poral and spatial distributions. The study demonstrates the
importance of tracking changing costs over time and being aware
that it is not only epidemiological models which are dynamic, but
also the economic factors associated with monitoring infectious
disease.
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